| scholarly article | Q13442814 |
| P2093 | author name string | Val J Watts | |
| Julie A Przybyla | |||
| P2860 | cites work | Functional Selectivity and Classical Concepts of Quantitative Pharmacology | Q22242288 |
| Adenosine A(2A) receptors assemble into higher-order oligomers at the plasma membrane | Q24315105 | ||
| Distinct functions of the two isoforms of dopamine D2 receptors | Q28138415 | ||
| Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications | Q28247343 | ||
| Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis | Q28268078 | ||
| The molecular logic of endocannabinoid signalling | Q29615356 | ||
| Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation | Q29616037 | ||
| Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens | Q30499463 | ||
| Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? | Q33211909 | ||
| What has been learnt from study of dopamine receptors in Parkinson's disease? | Q34491517 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| Simultaneous visualization of multiple protein interactions in living cells using multicolor fluorescence complementation analysis | Q34648424 | ||
| Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology | Q34742184 | ||
| Detection of heteromerization of more than two proteins by sequential BRET-FRET. | Q34790164 | ||
| The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction | Q36478275 | ||
| Prominence of the dopamine D2 short isoform in dopaminergic pathways | Q36507451 | ||
| A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization | Q36983708 | ||
| Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor | Q37086175 | ||
| Mutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization | Q37154000 | ||
| Fluorescent and bioluminescent protein-fragment complementation assays in the study of G protein-coupled receptor oligomerization and signaling | Q37367709 | ||
| Chemically distinct ligands promote differential CB1 cannabinoid receptor-Gi protein interactions. | Q40449973 | ||
| Constitutive endocytic cycle of the CB1 cannabinoid receptor. | Q40542809 | ||
| Characterization of a CNS cell line, CAD, in which morphological differentiation is initiated by serum deprivation. | Q41127708 | ||
| Modulation of neurotransmission by cannabinoids in the basal ganglia | Q41371378 | ||
| Dopamine activation of endogenous cannabinoid signaling in dorsal striatum | Q41646203 | ||
| Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors | Q42057708 | ||
| Activating mutations of the serotonin 5-HT2C receptor | Q42443753 | ||
| Sensitization of Neuronal A2A Adenosine Receptors after Persistent D2 Dopamine Receptor Activation | Q44622936 | ||
| D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor | Q44666474 | ||
| In utero marijuana exposure associated with abnormal amygdala dopamine D2 gene expression in the human fetus | Q45188663 | ||
| A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease | Q46491157 | ||
| Ligand-dependent oligomerization of dopamine D(2) and adenosine A(2A) receptors in living neuronal cells | Q46558819 | ||
| Changes in brain catecholamine mechanisms following perinatal exposure to marihuana | Q48297014 | ||
| Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. | Q48658239 | ||
| Identification of new fluorescent protein fragments for bimolecular fluorescence complementation analysis under physiological conditions. | Q50740719 | ||
| Detection of heteromers formed by cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer. | Q55035681 | ||
| Blockade of cannabinoid type 1 receptors augments the antiparkinsonian action of levodopa without affecting dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys | Q80609691 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dopamine | Q170304 |
| cannabinoid receptor | Q421237 | ||
| cannabinoids | Q422936 | ||
| CNR2 | Q17907844 | ||
| P304 | page(s) | 710-719 | |
| P577 | publication date | 2009-12-16 | |
| P1433 | published in | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
| P1476 | title | Ligand-induced regulation and localization of cannabinoid CB1 and dopamine D2L receptor heterodimers | |
| P478 | volume | 332 |
| Q35874442 | Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation |
| Q43075623 | An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors |
| Q50230269 | Antagonism of Dopamine Receptor 2 Long Affects Cannabinoid Receptor 1 Signaling in a Cell Culture Model of Striatal Medium Spiny Projection Neurons |
| Q37984087 | Cannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists |
| Q38212376 | Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands |
| Q35049600 | Components of the endocannabinoid and dopamine systems are dysregulated in Huntington's disease: analysis of publicly available microarray datasets |
| Q90660691 | Consequences of Perinatal Cannabis Exposure |
| Q39109270 | Crosstalk between dopamine D₂ receptors and cannabinoid CB₁ receptors regulates CNR1 promoter activity via ERK1/2 signaling. |
| Q86825974 | Delineation of domains within the cannabinoid CB1 and dopamine D2 receptors that mediate the formation of the heterodimer complex |
| Q34979178 | Development of a high-throughput screening paradigm for the discovery of small-molecule modulators of adenylyl cyclase: identification of an adenylyl cyclase 2 inhibitor |
| Q39906615 | Differential effects of AGS3 expression on D(2L) dopamine receptor-mediated adenylyl cyclase signaling |
| Q64076594 | Distinct Dopamine D₂ Receptor Antagonists Differentially Impact D₂ Receptor Oligomerization |
| Q35864824 | Dopamine D(2) Receptor-Mediated Heterologous Sensitization of AC5 Requires Signalosome Assembly |
| Q34345068 | Fluorescent protein complementation assays: new tools to study G protein-coupled receptor oligomerization and GPCR-mediated signaling. |
| Q46494176 | Functional Consequences of GPCR Heterodimerization: GPCRs as Allosteric Modulators |
| Q90292827 | GRK2 mediates TCR-induced transactivation of CXCR4 and TCR-CXCR4 complex formation that drives PI3Kγ/PREX1 signaling and T cell cytokine secretion |
| Q34658658 | Ghrelin-induced orexigenic effect in rats depends on the metabolic status and is counteracted by peripheral CB1 receptor antagonism |
| Q48128574 | Gαs signalling of the CB1 receptor and the influence of receptor number |
| Q38795549 | Heteromultimerization of cannabinoid CB(1) receptor and orexin OX(1) receptor generates a unique complex in which both protomers are regulated by orexin A. |
| Q34730200 | Lighting up multiprotein complexes: lessons from GPCR oligomerization |
| Q92856246 | Luminescence- and Fluorescence-Based Complementation Assays to Screen for GPCR Oligomerization: Current State of the Art |
| Q34548734 | Methods used to study the oligomeric structure of G-protein-coupled receptors |
| Q39405720 | Neurochemical evidence supporting dopamine D1-D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation |
| Q35882042 | Quinpirole elicits differential in vivo changes in the pre- and postsynaptic distributions of dopamine D₂ receptors in mouse striatum: relation to cannabinoid-1 (CB₁) receptor targeting. |
| Q36972027 | Striatal CB1 and D2 receptors regulate expression of each other, CRIP1A and δ opioid systems |
| Q28276192 | Sulfation of the FLAG epitope is affected by co-expression of G protein-coupled receptors in a mammalian cell model |
| Q48041725 | Two Affinity Sites of the Cannabinoid Subtype 2 Receptor Identified by a Novel Homogeneous Binding Assay. |
| Q34138944 | Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons |
| Q36300230 | Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease |
Search more.